Ceres Pharma signs 2 new partnerships in Romania

Sint-Denijs-Westrem, 15 October 2024  

Ceres Pharma Romania has signed two new partnerships for the marketing and distribution of interesting brands in the Romanian market: one with Karo Healthcare AB and the other for the Scholl footcare range.

Karo's Healthcare brands: Lamisil®, Lipobase®/Locobase®, Condyline® and Ultraproct® and Scholl's footcare range will be exclusively marketed and distributed by Ceres Pharma in the Romanian market from 15 October 2024.

These new distribution brands perfectly complement Ceres Pharma's own brand portfolio, which includes well-known Romanian brands such as Calmotusin®, Biseptol®, Dacia Plant®, Santaderm®, Santaderm ParasiteS®, … and further strengthen Ceres Pharma's position in Romania.

Ceres Pharma Romania has a turnover of +/- 22 million Euros, representing 17% of the Belgian based Ceres Pharma Group.

“6 months ago, a key project called UN1TY was launched across the company to create ‘one Ceres Pharma company’ in all our affiliates across Europe.  We are succeeding in presenting ourselves more strongly as a group in smaller local markets thanks to this unified image. A good example of this is attracting these partnerships”, says Mario Debel, CEO of Ceres Pharma.